Related Experiment Videos
[Biological treatments in obsessive-compulsive disorder]
S A Montgomery1, N A Fineberg, D Montgomery
1Hôpital Saint Mary, Londres.
L'Encephale
|July 1, 1990
Summary
Obsessive-compulsive disorder (OCD) is a serotonin-specific illness, with serotonin reuptake inhibitors demonstrating significant efficacy. These findings suggest a targeted approach for treating OCD symptoms.
Area of Science:
- Neuroscience
- Psychiatry
Context:
- Obsessive-compulsive disorder (OCD) is increasingly recognized as a condition with a specific neurochemical basis.
- Clinical evidence points towards the involvement of the serotonin system in OCD pathophysiology.
Purpose:
- To review and synthesize evidence supporting the serotonergic hypothesis of OCD.
- To evaluate the efficacy of serotonin-specific treatments for OCD.
Summary:
- Selective serotonin reuptake inhibitors (SSRIs) and clomipramine show consistent efficacy in treating OCD, outperforming placebo and other antidepressants in several studies.
- The lack of efficacy of non-serotonergic drugs further supports the specificity of serotonin's role in OCD.
- Evidence suggests that 5-HT uptake inhibitors have a direct anti-obsessional effect, even in the absence of depression, and may synergize with behavioral therapy.
Impact:
- These findings reinforce the serotonergic system as a primary target for OCD pharmacotherapy.
- The results advocate for the use of specific serotonergic agents in managing OCD.
- Further research into selective serotonergic probes is warranted to deepen understanding and refine treatment strategies.